Letter by Clark Regarding Article, “Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study”

Title
Letter by Clark Regarding Article, “Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study”
Authors
Keywords
-
Journal
STROKE
Volume 47, Issue 12, Pages e268-e268
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2016-11-16
DOI
10.1161/strokeaha.116.014920

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More